Navigation Links
NexGen Biofuels Ltd. (Nasdaq: NXGN) Announces Receipt of Nasdaq Delisting Determination
Date:2/27/2008

NEW YORK, February 27 /PRNewswire-FirstCall/ -- NexGen Biofuels Ltd. (f/k/a Healthcare Technologies Ltd.) (the "Company") announced today that on February 26, 2008, the Company received a letter from the Nasdaq Listing Qualification Panel, informing the Company that the Panel had determined to delist the Company's ordinary shares from The Nasdaq Stock Market following a determination by the Staff of the Nasdaq Listing Qualifications Department that the Company had failed to meet the Nasdaq listing standards for a reverse merger in connection with the Company's Plan of Arrangement with NexGen Biofuels Inc. Nasdaq will suspend trading of the Company's ordinary shares effective at the open of business on Thursday, February 28, 2008.

The Company believes that, following the recent filing of a Form 211 by a market maker, its ordinary shares will be eligible for trading on the OTC Bulletin Board.

For more information on NexGen Biofuels, Inc., visit http://www.nexgenbiofuels.net.

Safe harbor: This press release contains certain forward looking statements within the meaning of section 27a of the securities act of 1933 and section 21e of the securities exchange act of 1934. With the exception of historical information contained herein, the matters discussed in this press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement made by or on behalf of healthcare technologies ltd. Readers are referred to the documents filed by the company with the securities and exchange commission, specifically the form 8-k/a filed on February 12, 2008 that identifies important risks which could cause actual results to differ from those contained in the forward looking statements.

Contact: Eran Rotem CFO, +972-3-9277232


'/>"/>
SOURCE NexGen Biofuels Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"
2. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
3. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
4. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
5. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation
6. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
7. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q2/08 Review Issued By Scimitar Equity Research, Inc.
8. Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark.
9. QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Fourth Quarter and Year End 2007 Earnings and 2008 Guidance Conference Call on the Web
10. Healthcare Technologies Ltd. (NASDAQ: HCTL) Announces Extension of Letters of Intent to Acquire Majority Interest in Two Ethanol Plants
11. HealthCare Technologies Ltd. (NASDAQ: HCTL) Announces Receipt of NASDAQ Delisting Notice

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... California waste-to-energy firm claims first pla...ration, smallest footprint, salable pure gas, bypr... (PRWEB) December 15, 2009 -- The f...ive organic waste-to-energy process will take plac...ary. , , ,This biowaste process known as VRAD&cop...
(Date:11/30/2009)...hio, Nov. 30 The Ohio Capital Fund...on,s first minority business early-stage capital s...er 3, is called "Transforming the Landscape of Bus...Capital Summit." It will feature several speakers ...aders and local minority entrepreneurs. ,, "Th...
(Date:11/30/2009)... OF PRUSSIA, Pa., Nov. 30 Cadient...ing in interactive marketing services and solutio...e launch of its HATCH Consulting services gr...g strategic experts across a range of emerging are...sulting team is committed to guiding companies and...
(Date:11/30/2009)...ov. 30 The Michael J. F...y announced $1.5 million in total awards to six re...e-modifying therapies for Parkinson,s disease. The...o Drug Discovery for Parkinson,s Disease program,...lc (NYSE: ELN ), a neuroscience-based biotechnol...
Breaking Biology Technology:First Public Showing of Innovative Waste-to-Energy Process 2Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2Cadient Interactive Announces the Launch of HATCH Consulting Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 3The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3
... of Immunosyn Corporation (OTC Bulletin Board: IMY... http://www.wallst.net scheduled for November 16... http://www.wallst.net by 5 P.M. EST,on November...ing Immunosyn,s market potential,growth initiative...at,investors should watch for. "This interview is...
...eported today that it has filed a Form 12b-25 with... that its Form 10-QSB for the six months,ended Sep... 2007. However,AMDL expects to file the required r...y the Rules. Gary L. Dreher, President, stated: "A...ng and we need the additional time to,properly pre...
...e,Company (H&V), a leading global provider of nonw...ision(TM) technology platform, a collaborative,pro...rcialization of,breakthrough products. "HVision w...ed on,creating a new generation of products that e...ry," said Val Hollingsworth, H&V,s President and,C...
Other Biology Technology:WallSt.net Announces Upcoming Interview With CEO Of Immunosyn Corporation 2WallSt.net Announces Upcoming Interview With CEO Of Immunosyn Corporation 3AMDL Announces Filing of Extension on Third Quarter 2007 Form 10-QSB 2H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products 2
(Date:11/30/2009)...ontinue to rise scientists are presented with the ...pond and adapt. In a paper published in Insect Co...Trelles and Dr Miguel Rodriguez assess this challe...ximately 0.6˚C has already affected the Earth...ists and evolutionary biologists is to predict how...
(Date:11/30/2009)...research is the virus,s exquisite specialisation f...ional tools, like the humble lab mouse, can delive...hers writing in BioMed Central,s open access Jour...this problem by creating a mouse that has key feat...HIV. , George Kassiotis, from the Division of Im...
(Date:11/30/2009)...blished in the December 2009 print issue of The F...of control over their fertility that women have ha...found how and where androgenic hormones work in th...le fertility. This opens a promising avenue for th... also offers hope to those who cannot have childre...
Breaking Biology News(10 mins):How can scientists measure evolutionary responses to climate change? 2A reductionist approach to HIV research 2Abbott Declares 343rd Consecutive Quarterly Dividend 14129 1Medical Device Manufacturer MRPC Awarded ISO 13485 Certification 57543 1Medical Device Manufacturer MRPC Awarded ISO 13485 Certification 57543 2Global Med Technologies Inc s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wedn 57541 1Global Med Technologies Inc s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wedn 57541 2Global Med Technologies Inc s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wedn 57541 3
...ntrols blood sugar,s manufacture in a novel way: b...findings are reported in the April issue of the jo...The study found that mice deficient for KLF15, a m...scription factors, become severely lacking in the ...e body and the sole source for the brain—after a p...
...(IAVI) January 2007 Annual Issue of VAX, an editor...h published by IAVI, reports that 13 new preventiv...tries around the world in 2006. There are now more...ery continent. , This annual publication provides...e clinical trial activity worldwide. , Last yea...
...t wheat variety have led to a major advance in bre...et of papers published in the journal Plant Physio...s Nax1 and Nax2. The genes work by excluding salt ...ots, the other from the leaves. The discovery of t...ts. , "The two genes originally came from a whe...
Other Biology News:Blood sugar's manufacture limited by building blocks' supply 230+ AIDS vaccine clinical trials in 24 countries, research occurring on every continent 2Ancient genes used to produce salt-tolerant wheat 2
BD BioCoat Gelatin 100 mm Culture Dishes from BD Biosciences - Discovery Labware
Corning C ulture Dishes,100X20 mm,55Cm2,Sterile,6-Pack Carrier (6Pks Of 10 Dishes) from Sigma-Aldrich
BD Falcon Standard Cell Culture Dish from BD Biosciences - Discovery Labware
BD BioCoat Laminin 100 mm Culture Dishes from BD Biosciences - Discovery Labware
Biology Products: